1843 - 1953

London Health Sciences Centre – Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy Followed by HDR Brachy Boost for High Risk Adenocarcinoma of the Prostate (PCS-VI)

It seems we can’t find what you’re looking for. Perhaps searching can help.